Literature DB >> 27469250

The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.

Ming Shao1, Tian-Rui Xu2, Ce-Shi Chen3.   

Abstract

Targeted genome editing technology has been widely used in biomedical studies. The CRISPR-associated RNA-guided endonuclease Cas9 has become a versatile genome editing tool. The CRISPR/Cas9 system is useful for studying gene function through efficient knock-out, knock-in or chromatin modification of the targeted gene loci in various cell types and organisms. It can be applied in a number of fields, such as genetic breeding, disease treatment and gene functional investigation. In this review, we introduce the most recent developments and applications, the challenges, and future directions of Cas9 in generating disease animal model. Derived from the CRISPR adaptive immune system of bacteria, the development trend of Cas9 will inevitably fuel the vital applications from basic research to biotechnology and bio-medicine.

Keywords:  Animal models; CRISPR/Cas9; Gene therapy

Mesh:

Year:  2016        PMID: 27469250      PMCID: PMC4980067          DOI: 10.13918/j.issn.2095-8137.2016.4.191

Source DB:  PubMed          Journal:  Dongwuxue Yanjiu        ISSN: 0254-5853


  129 in total

1.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

Review 2.  Pathomechanisms of discogenic low back pain in humans and animal models.

Authors:  Seiji Ohtori; Gen Inoue; Masayuki Miyagi; Kazuhisa Takahashi
Journal:  Spine J       Date:  2014-03-20       Impact factor: 4.166

Review 3.  Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.

Authors:  Jennifer L Gori; Patrick D Hsu; Morgan L Maeder; Shen Shen; G Grant Welstead; David Bumcrot
Journal:  Hum Gene Ther       Date:  2015-07       Impact factor: 5.695

4.  Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.

Authors:  Bin Shen; Jun Zhang; Hongya Wu; Jianying Wang; Ke Ma; Zheng Li; Xueguang Zhang; Pumin Zhang; Xingxu Huang
Journal:  Cell Res       Date:  2013-04-02       Impact factor: 25.617

Review 5.  Modeling Disease In Vivo With CRISPR/Cas9.

Authors:  Lukas E Dow
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

6.  Natural Variation in Gene Expression Modulates the Severity of Mutant Phenotypes.

Authors:  Victoria Vu; Adrian J Verster; Michael Schertzberg; Tungalag Chuluunbaatar; Mark Spensley; Djina Pajkic; G Traver Hart; Jason Moffat; Andrew G Fraser
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

7.  Rapid and marker-free refactoring of xylose-fermenting yeast strains with Cas9/CRISPR.

Authors:  Ching-Sung Tsai; In Iok Kong; Anastashia Lesmana; Gyver Million; Guo-Chang Zhang; Soo Rin Kim; Yong-Su Jin
Journal:  Biotechnol Bioeng       Date:  2015-06-30       Impact factor: 4.530

8.  CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.

Authors:  Puping Liang; Yanwen Xu; Xiya Zhang; Chenhui Ding; Rui Huang; Zhen Zhang; Jie Lv; Xiaowei Xie; Yuxi Chen; Yujing Li; Ying Sun; Yaofu Bai; Zhou Songyang; Wenbin Ma; Canquan Zhou; Junjiu Huang
Journal:  Protein Cell       Date:  2015-04-18       Impact factor: 14.870

9.  The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo.

Authors:  Su-Ru Lin; Hung-Chih Yang; Yi-Ting Kuo; Chun-Jen Liu; Ta-Yu Yang; Ku-Chun Sung; You-Yu Lin; Hurng-Yi Wang; Chih-Chiang Wang; Yueh-Chi Shen; Fang-Yi Wu; Jia-Horng Kao; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-19       Impact factor: 10.183

10.  Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  5 in total

Review 1.  Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling.

Authors:  Yosef Tsegaye Dabi; Sisay Teka Degechisa
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-11       Impact factor: 3.249

2.  Creating animal models, why not use the Chinese tree shrew (Tupaia belangeri chinensis)?

Authors:  Yong-Gang Yao
Journal:  Zool Res       Date:  2017-05-18

Review 3.  Breast cancer animal models and applications.

Authors:  Li Zeng; Wei Li; Ce-Shi Chen
Journal:  Zool Res       Date:  2020-09-18

Review 4.  Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Biomed Res Int       Date:  2020-01-02       Impact factor: 3.411

Review 5.  Generation of genetically-engineered animals using engineered endonucleases.

Authors:  Jong Geol Lee; Young Hoon Sung; In-Jeoung Baek
Journal:  Arch Pharm Res       Date:  2018-05-17       Impact factor: 4.946

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.